Cable Hill Partners’s West Pharmaceutical WST Stock Holding History

Cable Hill Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-28	Closed	-$3K	–	708
2019 Q1	$3K	Hold	28	–	–	﹤0.01%	722
2018 Q4	$3K	Hold	28	–	–	﹤0.01%	684
2018 Q3	$3K	Sell	28 -5	-15%	-$561	﹤0.01%	680
2018 Q2	$3K	Hold	33	–	–	﹤0.01%	797
2018 Q1	$3K	Sell	33 -150	-82%	-$14K	﹤0.01%	792
2017 Q4	$18K	Hold	183	–	–	0.01%	441
2017 Q3	$18K	Sell	183 -4	-2%	-$362	0.01%	430
2017 Q2	$17K	Sell	187 -1	-0.5%	-$92	0.01%	290
2017 Q1	$15K	Sell	188 -14	-7%	-$1.17K	0.01%	318
2016 Q4	$17K	Hold	202	–	–	0.01%	298
2016 Q3	$15K	Sell	202 -51	-20%	-$4.05K	0.01%	343
2016 Q2	$20K	Sell	253 -23	-8%	-$1.67K	0.01%	251
2016 Q1	$20K	Buy	276 +16	+6%	+$963	0.02%	239
2015 Q4	$16K	Buy	260 +14	+6%	+$842	0.01%	280
2015 Q3	$14K	Sell	246 -488	-66%	-$28.4K	0.01%	314
2015 Q2	$44K	Hold	734	–	–	0.03%	162
2015 Q1	$41K	Sell	734 -151	-17%	-$8.05K	0.03%	161
2014 Q4	$48K	Buy	+885	New	+$44.3K	0.05%	142

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cable Hill Partners's WST Position: Q2 2019 in Review

Cable Hill Partners sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 28 shares — an estimated $3K sold.

Cable Hill Partners first reported a position in WST in Q4 2014 and held it in 18 quarters. The position peaked at $48K in Q4 2014. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

Cable Hill Partners reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 28 West Pharmaceutical shares in Q2 2019, an estimated $3K.
Cable Hill Partners first reported a position in West Pharmaceutical in Q4 2014 and held it in 18 quarters.
Cable Hill Partners's West Pharmaceutical position peaked at $48K in Q4 2014.
374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.